Freyherr International Group plc is the UK parent company of a group engaged in the production of medicinal cannabis products. The group is committed to research, development, cultivation, processing and production of APIs, final products and dosing packaging. Operations are centered in Slovenia and the Group principally operates within the EU.
Freyherr Pharma d.o.o. is the pharmaceutical arm of the Group and holds an EU GMP certificate. It operates from a certified production facility, manufactures CBD products for the Group and produces white label CBD products supplying them to various EU countries. Its Quality assurance department is specialized
in EU pharmaceutical quality system, considering cannabis specifics. An important strength of Freyherr Pharma is also a Research and development department with remarkable expertise in the cultivation, processing, formulation and legal and regulatory compliance of cannabis-based products. Freyherr Pharma is currently growing cannabis varieties from EU Plant database in Slovenia and has invested in cannabis production facilities in other jurisdictions.